Skip to main content
Signal8

Goldwasser Meredith

SEC insider (Form 3/4/5 filer). CIK 0001922606. SVP, Strategy & Corporate Ops. at Prime Medicine, Inc. (PRME). 1 reported Form 4/5 transaction since Sep 2024; latest on Feb 27, 2025. Located in CAMBRIDGE, MA.

Companies Goldwasser Meredith has filed insider reports for

  • Prime Medicine, Inc. (PRME): Officer, SVP, Strategy & Corporate Ops.
Goldwasser Meredith profile photo

Goldwasser Meredith

CIK: 0001922606

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Prime Medicine, Inc. logo
PRME

Prime Medicine, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Prime Medicine, Inc. logo
    PRME

    Prime Medicine, Inc.

    Feb 27, 2025
    Award

    Stock Option (right to buy)

    Direct
    90.5K shares-

1-1 of 1